Protein kinase C delta enhances proliferation and survival of murine mammary cells

Valeria C Grossoni1, Karina B Falbo, Marcelo G Kazanietz

  • 1Research Area, Institute of Oncology Angel H. Roffo, University of Buenos Aires, Buenos Aires, Argentina.

Molecular Carcinogenesis
|January 16, 2007
PubMed

Insights

Protein kinase C delta (PKCdelta) surprisingly promotes mammary cell proliferation and survival, contradicting its proposed tumor suppressor role. Further research is needed to understand its context-dependent functions in cancer therapy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Protein kinase C delta (PKCdelta) is a serine-threonine kinase implicated in cell proliferation and apoptosis.
  • Previous studies suggested PKCdelta acts as a tumor suppressor, inhibiting cell growth.

Purpose of the Study:

  • To investigate the role of PKCdelta in mammary cell proliferation and survival.
  • To determine the signaling pathways modulated by PKCdelta in immortalized mammary cells.

Main Methods:

  • Overexpression of PKCdelta in murine NMuMG mammary cells.
  • Assessing [3H]-thymidine incorporation and cell proliferation.
  • Analyzing extracellular signal-regulated kinase (ERK)-mitogen-activated protein kinase (MAPK) activation.
  • Evaluating cyclin D1 expression, Rb phosphorylation, and Akt pathway activation.
  • Testing resistance to apoptotic stimuli (serum deprivation, doxorubicin).

Main Results:

  • PKCdelta overexpression significantly increased cell proliferation and [3H]-thymidine incorporation.
  • PKCdelta enhanced ERK-MAPK activation, cyclin D1 expression, and Rb hyperphosphorylation.
  • Ectopic PKCdelta expression promoted anchorage-independent growth.
  • PKCdelta overexpressors exhibited increased resistance to apoptosis via Akt pathway hyperactivation.

Conclusions:

  • PKCdelta acts as a positive modulator of proliferation and survival signals in immortalized mammary cells.
  • PKCdelta's function is context-dependent, necessitating careful study in different cell types.
  • Caution is advised when considering PKCdelta as a cancer therapy target due to its complex roles.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...